Back to all presentations
Carnegie interview with our CEO Tord Labuda
Our CEO Tord Labuda, was interview by Carnegie, discussing the latest clinical results for the Alzheimer's vaccine, partner plans, and the next steps in the development of the vaccine.
View the interview below, in Swedish.